Yatharth Hospital & Trauma Care Services Limited Just Beat Revenue By 6.6%: Here's What Analysts Think Will Happen Next

Shareholders might have noticed that Yatharth Hospital & Trauma Care Services Limited (NSE:YATHARTH) filed its third-quarter result this time last week. The early response was not positive, with shares down 5.2% to ₹409 in the past week. Results overall were respectable, with statutory earnings of ₹14.46 per share roughly in line with what the analysts had forecast. Revenues of ₹2.2b came in 6.6% ahead of analyst predictions. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

See our latest analysis for Yatharth Hospital & Trauma Care Services

Taking into account the latest results, the consensus forecast from Yatharth Hospital & Trauma Care Services' three analysts is for revenues of ₹11.4b in 2026. This reflects a huge 38% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to swell 13% to ₹17.13. Before this earnings report, the analysts had been forecasting revenues of ₹12.7b and earnings per share (EPS) of ₹23.17 in 2026. From this we can that sentiment has definitely become more bearish after the latest results, leading to lower revenue forecasts and a pretty serious reduction to earnings per share estimates.

The consensus price target fell 24% to ₹561, with the weaker earnings outlook clearly leading valuation estimates. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. Currently, the most bullish analyst values Yatharth Hospital & Trauma Care Services at ₹644 per share, while the most bearish prices it at ₹410. These price targets show that analysts do have some differing views on the business, but the estimates do not vary enough to suggest to us that some are betting on wild success or utter failure.

Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. We can infer from the latest estimates that forecasts expect a continuation of Yatharth Hospital & Trauma Care Services'historical trends, as the 29% annualised revenue growth to the end of 2026 is roughly in line with the 28% annual growth over the past five years. Compare this with the broader industry, which analyst estimates (in aggregate) suggest will see revenues grow 18% annually. So it's pretty clear that Yatharth Hospital & Trauma Care Services is forecast to grow substantially faster than its industry.

The Bottom Line

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. Regrettably, they also downgraded their revenue estimates, but the latest forecasts still imply the business will grow faster than the wider industry. Furthermore, the analysts also cut their price targets, suggesting that the latest news has led to greater pessimism about the intrinsic value of the business.

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. At Simply Wall St, we have a full range of analyst estimates for Yatharth Hospital & Trauma Care Services going out to 2027, and you can see them free on our platform here..

Another thing to consider is whether management and directors have been buying or selling stock recently. We provide an overview of all open market stock trades for the last twelve months on our platform, here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.